In Search of Desire: Mimicry, MAP, and Crohn's Disease

Gastroenterology

Volumn 131, Issue 1, 2006, Pages 312-314

  Braun, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT;

ANTIMICROBIAL THERAPY; AUTOIMMUNITY; CLINICAL OBSERVATION; CROHN DISEASE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INFLAMMATORY DISEASE; MOLECULAR MIMICRY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM PARATUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT; VALIDATION PROCESS;

EID: 33745751945     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.05.042     Document Type: Editorial

References (30)

1. Sechi L.A., Scanu A.M., Molicotti P., Cannas S., Mura M., Dettori G., Fadda G., and Zanetti S. Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol 100 (2005) 1529-1536
2. Autschbach F., Eisold S., Hinz U., Zinser S., Linnebacher M., Giese T., Loffler T., Buchler M.W., and Schmidt J. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 54 (2005) 944-949
3. Selby W.S. Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease. Lancet 364 (2004) 1013-1014
4. Naser S.A., Ghobrial G., Romero C., and Valentine J.F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364 (2004) 1039-1044
5. El Zaatari F.A., Naser S.A., Hulten K., Burch P., and Graham D.Y. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr Microbiol 39 (1999) 115-119
6. Suenaga K., Yokoyama Y., Nishimori I., Sano S., Morita M., Okazaki K., and Onishi S. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci 44 (1999) 1202-1207
7. Francois B., Krishnamoorthy R., and Elion J. Comparative study of Mycobacterium paratuberculosis strains isolated from Crohn's disease and Johne's disease using restriction fragment length polymorphism and arbitrarily primed polymerase chain reaction. Epidemiol Infect 118 (1997) 227-233
8. Gui G.P.H., Thomas P.R.S., Tizard M.L.V., Lake J., Sanderson J.D., and Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 39 (1997) 393-400
9. Collins M.T., Lisby G., Moser C., Chicks D., Christensen S., Reichelderfer M., Hoiby N., Harms B.A., Thomsen O.O., Skibsted U., and Binder V. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol 38 (2000) 4373-4381
10. Thomas G.A., Swift G.L., Green J.T., Newcombe R.G., Braniff-Mathews C., Rhodes J., Wilkinson S., Strohmeyer G., and Kreuzpainter G. Controlled trial of antituberculous chemotherapy in Crohn's disease. a five year follow up study. Gut 42 (1998) 497-500
11. Ryan P., Kelly R.G., Lee G., Collins J.K., O'Sullivan G.C., O'Connell J., and Shanahan F. Bacterial DNA within granulomas of patients with Crohn's disease-detection by laser capture microdissection and PCR. Am J Gastroenterol 99 (2004) 1539-1543
12. Ellingson J.L., Cheville J.C., Brees D., Miller J.M., and Cheville N.F. Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. Clin Med Res 1 (2003) 217-226
13. Clarkston W.K., Presti M.E., Petersen P.F., Zachary P.E.J., Fan W.X., Leonardi C.L., Vernava A.M., Longo W.E., and Kreeger J.M. Role of Mycobacterium paratuberculosis in Crohn's disease. a prospective, controlled study using polymerase chain reaction. Dis Colon Rectum 41 (1998) 195-199
14. Chiba M., Fukushima T., Horie Y., Iizuka M., and Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease. J Gastroenterol 33 (1998) 482-487
15. Cellier C., De Beenhouwer H., Berger A., Penna C., Carbonnel F., Parc R., Cugnenc P.H., Le Quintrec Y., Gendre J.P., Barbier J.P., and Portaels F. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol 22 (1998) 675-678
16. Braun J., and Targan S.R. Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel disease. Adv Exp Med Biol 579 (2006) 209-218
17. Lu W., Hisatsune A., Koga T., Kato K., Kuwahara I., Lillehoj E.P., Chen W., Cross A.S., Gendler S.J., Gewirtz A.T., and Kim K.C. Cutting edge. enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J Immunol 176 (2006) 3890-3894
18. Tallant T., Deb A., Kar N., Lupica J., de Veer M.J., and DiDonato J.A. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol 4 (2004) 33
19. Targan S.R., Landers C.J., Yang H., Lodes M.J., Cong Y., Papadakis K.A., Vasiliauskas E., Elson C.O., and Hershberg R.M. Antibodies to CBir1 Flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128 (2005) 2020-2028
20. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., and Hershberg R.M. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113 (2004) 1296-1306
21. Polymeros D., Bogdanos D.P., Day R., Arioli D., Vergani D., and Forbes A. Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology 131 (2006) 85-96
22. Casali P., and Notkins A.L. Probing the human B-cell repertoire with EBV. polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 7 (1989) 513-535
23. Paton A.W., Jennings M.P., Morona R., Wang H., Focareta A., Roddam L.F., and Paton J.C. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 128 (2005) 1219-1228
24. Kirvan C.A., Swedo S.E., Heuser J.S., and Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9 (2003) 914-920
25. Moudgil K.D., Kim E., Yun O.J., Chi H.H., Brahn E., and Sercarz E.E. Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol 166 (2001) 4237-4243
26. Ohteki T., Hessel A., Bachmann M.F., Zakarian A., Sebzda E., Tsao M.S., McKall-Faienza K., Odermatt B., and Ohashi P.S. Identification of a cross-reactive self ligand in virus-mediated autoimmunity. Eur J Immunol 29 (1999) 2886-2896
27. Hemmer B., Gran B., Zhao Y., Marques A., Pascal J., Tzou A., Kondo T., Cortese I., Bielekova B., Straus S.E., McFarland H.F., Houghten R., Simon R., Pinilla C., and Martin R. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 5 (1999) 1375-1382
28. Benoist C., and Mathis D. The pathogen connection. Nature 394 (1998) 227-228
29. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., and Sarvetnick N. Diabetes induced by Coxsackie virus. initiation by bystander damage and not molecular mimicry. Nat Med 4 (1998) 781-785
30. Sicilia J. Olga Orozco. in search of desire. Siempre! (1999) 6570